Company intelligence / Profile preview

opTricon

Berlin, Germany

Ownership: Private
Development stage: Other

Overview

opTricon GmbH has supplied more than 40,000 readers to over 300 customers as an OEM manufacturer since its founding in 2005. The readers are IVD and FDA approved.

Therapeutic areas: Other
Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Biosynex SA (France)Chembio Diagnostics, Inc.

Beyond the preview

Go deeper on opTricon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on opTricon.

Explore the full profile